Introduction
Acute ischemic stroke (AIS) is a medical emergency that requires prompt intervention to minimize long-term disability and improve outcomes. In recent years, mechanical thrombectomy has emerged as a highly effective treatment option for AIS patients with large vessel occlusions (LVO) in the anterior circulation. The use of advanced imaging criteria, such as the DAWN and DEFUSE 3 criteria, has further refined patient selection for thrombectomy, leading to improved outcomes in select patient populations. This article will delve into the Hermes criteria thrombectomy, focusing on endovascular thrombectomy criteria, thrombectomy imaging criteria, guidelines, eligibility criteria, indications, and the latest advancements in thrombectomy research.
Endovascular Thrombectomy Criteria
The Hermes criteria thrombectomy outlines specific criteria that must be met for patients to be considered eligible for endovascular thrombectomy. These criteria typically include:
1. Time window: Patients must present within 6-16 hours of their last known normal, emphasizing the importance of timely intervention in AIS cases.
2. Large vessel occlusion (LVO): Patients must have a confirmed LVO in the anterior circulation, such as the internal carotid artery, middle cerebral artery, or anterior cerebral artery.
3. Imaging criteria: Patients should meet specific imaging criteria, such as the DAWN or DEFUSE 3 criteria, which assess salvageable brain tissue and penumbral patterns to identify candidates for thrombectomy.
Thrombectomy Imaging Criteria
Advanced imaging plays a crucial role in identifying patients who are most likely to benefit from thrombectomy. The DAWN and DEFUSE 3 criteria are commonly used to assess eligibility for thrombectomy based on imaging findings. These criteria evaluate factors such as ischemic core volume, penumbral tissue, and mismatch ratios to determine the extent of salvageable brain tissue and predict favorable outcomes following thrombectomy.
Endovascular Thrombectomy Guidelines
Several guidelines and consensus statements have been developed to provide recommendations on the use of endovascular thrombectomy in AIS patients. These guidelines emphasize the importance of timely intervention, patient selection based on imaging criteria, and the use of advanced technologies in performing thrombectomy procedures. Key guidelines include those from the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organisation (ESO).
ELVO Thrombectomy Criteria
ELVO (Emergent Large Vessel Occlusion) thrombectomy criteria refer to the specific criteria used to identify patients with large vessel occlusions who are candidates for emergent thrombectomy. ELVO criteria typically include the presence of a proximal arterial occlusion in the anterior circulation, such as the intracranial internal carotid artery or middle cerebral artery, and evidence of salvageable brain tissue on imaging studies.
Thrombectomy Candidacy Criteria
Thrombectomy candidacy criteria encompass a range of factors that determine a patient's suitability for endovascular thrombectomy. These criteria include time window for intervention, presence of LVO in the anterior circulation, imaging findings indicating salvageable brain tissue, absence of contraindications to thrombectomy, and overall clinical status of the patient. Multidisciplinary teams comprising neurologists, interventional neuroradiologists, and stroke specialists collaborate to assess patient eligibility for thrombectomy based on these criteria.
Indications for Thrombectomy
Thrombectomy is indicated in AIS patients who meet specific criteria for endovascular intervention, including those with LVO in the anterior circulation, salvageable brain tissue on imaging studies, and within the recommended time window for intervention. Patients who demonstrate clinical improvement following thrombectomy typically experience better outcomes in terms of functional recovery and reduced disability compared to those who do not undergo thrombectomy.
Thrombectomy RCTs and Clinical Trials
Numerous randomized controlled trials (RCTs) and clinical trials have been conducted to evaluate the efficacy and safety of thrombectomy in AIS patients. Landmark studies such as the MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, and REVASCAT trials have demonstrated the significant benefits of thrombectomy in improving functional outcomes and reducing disability in select patient populations. Ongoing research continues to explore new technologies, imaging modalities, and treatment strategies to further enhance the outcomes of thrombectomy in AIS patients.
current url：https://ahivif.c425n.com/news/hermes-criteria-thrombectomy-34568